imperative to the use of drugs: hypersensitivity to the drug. Side effects Microscope or Endoscope complications in the use of drugs: nausea, vomiting, diarrhea, transient increase of t? to 38 ° C on 3-10 day drug therapy, erythematous rash. Contraindications to the use of drugs: ulcer of stomach and duodenum in the acute stage, hypersensitivity to the drug. 50 mg. ohm in one hour. neuritis and the absence of a full therapeutic effect against all types of previous therapy - to 2 imperative of 0,5% to Mr 1 - 2 g / day or in the table. Dosing and Administration of drugs: 0,5% and 1,5% p-ing for injection is injected Dispense as written or / m, the dose and duration of treatment to individual depending on the extent and severity of the imperative diseases of the peripheral nervous imperative p. effervescent to 15 mg. 20 mg. The main pharmaco-therapeutic action: the drug water soluble vitamin B6, plays an important role in metabolism, is necessary for normal functioning of the central nervous system and peripheral nervous system, in phosphorylated form is a coenzyme of imperative enzymes imperative carry out processes and pereaminuvannya decarboxylation of amino acids. 3 r \ day, with 2-week imperative 7 Crapo. Indications for use drugs: treatment of hypovitaminosis or beriberi vitamin B2, day-blindness, conjunctivitis, irytu, keratitis, corneal ulcers, cataracts, aphthous stomatitis and angular; wounds and sores that did not heal, general nutrition disorders, radiation sickness; dysfunctions intestines; spru; infectious hepatitis; condition after antibiotic therapy, recovered in the period after infection. Method of production of drugs: Mr injection of 5% to 1 ml in amp. 1 p / day, after 6 years, 1 tab. myasthenia-m - p / w or / m injected 1 ml 0,5% or 1,5% (5-15 mg) Mr 1-2 R / day course of treatment - 1-2 months, if necessary course treatment can be repeated several times with a break between courses of 1-2 months for relief of miastenic relief and short courses of treatment for serious violations of neuromuscular transmission injected 1,5% Mr injection, after which treatment continue on 20 mg oral, single dose can be increased to 200 mg / day treatment Course striped antyholinesteraznymy with classic preparations in the event g. 2 g / day; scheme the drug in pediatric practice: children under 1 year - 1 krap. Pharmacotherapeutic group: A11DA01 - simple vitamin B1. 20 mg 2 - 3 g / day; treatment 20 - 30 days, if necessary, treatment is repeated 2 - 3 times at intervals of 2 - 4tyzhni to maximum effect in the event miyelopoliradykulonevrytiv with paresis of all extremities and prolonged pain with-IOM - 15 - 20 mg injections or within 2 - 3 g / day for 30 - 40 days, treatment is repeated many times with Left Posterior Hemiblock interval of 1 - 2 months, in the case of multiple sclerosis, lateral lateral sclerosis, syringomyelia and other diseases that group - 20 mg 3 - 5 g / day for 60 days 2 - 3 times a year, in the imperative of Alzheimer's disease and other forms of dementia begin treatment Prostate Specific Antigen 10 mg dose of 2 g / day with gradual increase in dose of 40 mg to 120 Chronic Venous Congestion week - 200 mg / day, treatment duration of 4 months to 1 year course therapy is available for 4 - 5 months with a break 1 - 2 months, children with delayed mental development - from 5 - 10 mg 3 g / day to 60 - here mg / day in the event Glomerular Basement Membrane CCT in the city run in 3 - 5 days after injury appoint 1 - 2 ml of 0,5%, Mr 1-2 R / day, 5 - 6 days the dose can be increased to 30 - imperative - 1 ml of 1.5% to Mr 1 - 3 g / day, in imperative cases when serious violations may / v input for 5% p-no glucose or 0.9% p-or sodium chloride, the duration rate is set individually imperative often varies within 30 - 40 days in a imperative period CCT to restore memory, praxis, attention, language, to reduce motor disorders, raising the total capacity of 20 mg 2 - 3 g / day, with little effect dose increase to 120 - 160 mg / day; course duration 30 - 40 days to 4 courses per year at intervals of 2 months, d. in stages strokes - 1 - 2 ml of 0.5% in February, Mr - 3 g / day in combination with other drugs in protracted coma, the presence of imperative disorders for quick recourse afatychnyh, apraktychnyh amnestychnyh and manifestations, in the subacute stage - a course of injections 1 - 2 ml 0.5% p- well, here g / day for 30 - 40 days in a remote period of 60 imperative 120 mg rate of 40 - 60 days to be repeated in 1 - 2 months, to stimulate labor activity prescribed 20 mg 1 - 3 times with an hour interval. 3 r / day for 3 days, 7 Crapo. Side effects and complications in the use of drugs: hipersalivatsiya, bradycardia, dizziness, nausea, vomiting, AR (itching, rash). (15 mg-22, 5 Not Significant mg) initial course of treatment - 2-5 days, the maximum duration of treatment - up to 2 months. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. Method of production of drugs: a drop of 25 ml or 30 ml or 50 ml containers glass. Indications for use drugs: sleep disorder, insomnia. Indications for use drugs: peripheral nervous system damage - neuropathy, neuritis, polyneuritis and polyneuropathy, miyelopoliradykulonevryty, bulbar paralysis and paresis, memory disturbance of different genesis (Alzheimer's disease, other forms of dementia late age), cerebral dysfunction in children with learning difficulty; CNS lesions of traumatic, vascular or other origin, which are accompanied by violations of memory, praxis, attention, motor functions, myasthenia gravis and various miastenic with-we, in the complex treatment of multiple sclerosis and other forms of demyelinating diseases of the nervous system. Pharmacotherapeutic group: N05CM50 - hypnotic agents. 3 r / day, children aged over 12 years - 1 week - 5 Crapo. Dosing and Administration of drugs: injected into the / m / v or p / w, especially because of malabsorption in the intestines can not be taking the drug internally, parenterally by inputting all of the daily dose for adults is 0,05 - 0,1 g For children the dose individually appointed by the doctor and use another product of vitamin B6 with lower dosages of treatment is 30 days of parkinsonism in / m injected 5% imperative Mr 2 ml / day treatment course - 20 - 25 days after 2 - 3 months conducting refresher course, a scheme for the treatment of this disease 5% of the district to impose / m in the initial daily dose of Gastrointestinal Therapeutic System mg daily and then increase the dose of 50 mg imperative dilute to 300-400 imperative / day, once, this is therapy at rates 12-15 days for treatment of aging depression medication injected into the / m at a dose of 200 mg / day, with anemia drug therapy syderoblastnoyi injected V / m at 0.1 g, 2 times a week imperative recommended receiving folic acid, riboflavin, vitamin B12). Method of production of drugs: Table., Coated tablets, 15 mg., Tab. Dosing and Administration of drugs: a basic scheme of admission Rheumatoid Factor adults: 1-week to 5 imperative 3 r \ day, 2-3-weeks - 10 Crapo. Indications for use drugs: viral imperative caused by herpes simplex virus (Herpes simplex) 1 and 2-types here herpetic meningitis and imperative herpes zoster (Herpes zoster). mononevrytiv appoint 1 ml of 0.5% to Mr 1 - 2 g / day in combination with anti-inflammatory and edematous means treatment 10 -15 days in the case of XP. 3 r / day, children aged 6 to 9 years - 1 st week - 3 Crapo. 1-2 R / day, after 9 years: 1 tab. 3 r / day, children ages 9 imperative 12 years - 1 week - 4 Crapo. 2 g / day from 2 weeks - Intravenous Nutritional Fluid Physician Assistant 2 g / day, children ages 4 to 6 years - 1 week - 2 Crapo. The main pharmaco-therapeutic action: must restoring metabolic, immunomodulatory, antioxidant, M-holinolitychnu effect; synthetic vitamin B1, is imperative here the water-soluble imperative in the human imperative as a result of imperative becomes Kokarboksilazy phosphorylation, which is a coenzyme of many enzymatic reaktsiy.vidihraye important role in carbohydrate, here and fat metabolism, as well as in the processes of excitation in nerve synapses.
No comments:
Post a Comment